Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Capital Expenditures (2011 - 2025)

Updated

Analysis

Abvc Biopharma (ABVC) Capital Expenditures (2011 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 1.36 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 301.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 237.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 573.00 Mn
10 Abvc Biopharma 24.28 Mn 21.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 373.00
Sep 30, 2023 -419,374.00
Dec 31, 2022 89.00
Sep 30, 2022 4,357.00
Jun 30, 2022 22,026.00
Mar 31, 2022 93,220.00
Dec 31, 2011 350.00
API Access

Abvc Biopharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABVC&period=max&api_key=YOUR_API_KEY